These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31649726)

  • 1. Establishing a Multi-Country Sickle Cell Disease Registry in Africa: Ethical Considerations.
    Munung NS; Nembaware V; de Vries J; Bukini D; Tluway F; Treadwell M; Sangeda RZ; Mazandu G; Jonas M; Paintsil V; Nnodu OE; Balandya E; Makani J; Wonkam A
    Front Genet; 2019; 10():943. PubMed ID: 31649726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana.
    Paintsil V; Amuzu EX; Nyanor I; Asafo-Adjei E; Mohammed AR; Yawnumah SA; Oppong-Mensah YG; Nguah SB; Obeng P; Dogbe EE; Jonas M; Nembaware V; Mazandu G; Ohene-Frempong K; Wonkam A; Makani J; Ansong D; Osei-Akoto A;
    Front Genet; 2022; 13():802355. PubMed ID: 35281803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assent, parental consent and reconsent for health research in Africa: thematic analysis of national guidelines and lessons from the SickleInAfrica registry.
    Munung NS; Nembaware V; Osei-Tutu L; Treadwell M; Chide OE; Bukini D; Tutuba H; ; Wonkam A
    BMC Med Ethics; 2022 Dec; 23(1):130. PubMed ID: 36482457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica.
    Paintsil V; Ally M; Isa H; Anie KA; Mgaya J; Nkanyemka M; Nembaware V; Oppong-Mensah YG; Ndobho F; Chirande L; Makubi A; Nnodu O; Wonkam A; Makani J; Ohene-Frempong K
    Front Genet; 2022; 13():1052179. PubMed ID: 36712852
    [No Abstract]   [Full Text] [Related]  

  • 5. Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium.
    Nnodu OE; Osei-Akoto A; Nembaware V; Kent J; Nwegbu M; Minja I; Mazandu GK; Makani J; Wonkam A
    Front Genet; 2022; 13():805806. PubMed ID: 35783259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
    Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
    OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a database for sickle cell disease patient mapping and survival tracking: The sickle pan-african research consortium Nigeria example.
    Nnodu O; Madu A; Chianumba R; Isa HA; Olanrewaju I; Osagie S; Oyekanmi N; Sangeda RZ; Stewart A; Nembaware V; Morrice J; Jonas M; Mazandu G; Wonkam A; Owolabi O
    Front Genet; 2022; 13():1041462. PubMed ID: 36406113
    [No Abstract]   [Full Text] [Related]  

  • 8. Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania.
    Anie KA; Olayemi E; Paintsil V; Owusu-Dabo E; Adeyemo TA; Sani MU; Galadanci NA; Nnodu O; Tluway F; Adjei DN; Mensah P; Sarfo-Antwi J; Nwokobia H; Gambo A; Benjamin A; Salim A; Osae-Larbi JA; Ofori-Acquah SF;
    BMJ Open; 2021 Jul; 11(7):e048208. PubMed ID: 34301659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative options for sickle cell disease in Africa: Approach in Tanzania.
    Makani J;
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):66-70. PubMed ID: 32201150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry.
    Glassberg JA; Linton EA; Burson K; Hendershot T; Telfair J; Kanter J; Gordeuk VR; King AA; Melvin CL; Shah N; Hankins JS; Epié AY; Richardson LD;
    Orphanet J Rare Dis; 2020 Jul; 15(1):178. PubMed ID: 32635939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.
    Diallo DA; Guindo A
    Curr Opin Hematol; 2014 May; 21(3):210-4. PubMed ID: 24613937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National ethics guidance in Sub-Saharan Africa on the collection and use of human biological specimens: a systematic review.
    Barchi F; Little MT
    BMC Med Ethics; 2016 Oct; 17(1):64. PubMed ID: 27770794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa.
    Osafo C; Raji YR; Burke D; Tayo BO; Tiffin N; Moxey-Mims MM; Rasooly RS; Kimmel PL; Ojo A; Adu D; Parekh RS;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2279-87. PubMed ID: 26138261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A renal registry for Africa: first steps.
    Davids MR; Eastwood JB; Selwood NH; Arogundade FA; Ashuntantang G; Benghanem Gharbi M; Jarraya F; MacPhee IA; McCulloch M; Plange-Rhule J; Swanepoel CR; Adu D
    Clin Kidney J; 2016 Feb; 9(1):162-7. PubMed ID: 26798479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ethics of Introducing GMOs into sub-Saharan Africa: Considerations from the sub-Saharan African Theory of Ubuntu.
    Komparic A
    Bioethics; 2015 Nov; 29(9):604-12. PubMed ID: 26481201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building research capacity for sickle cell disease in Africa: Lessons and challenges from establishing a birth cohort in Tanzania.
    Nkya S; Njiro BJ; Ngowi D; Solomon D; Kaywanger F; Nyangasa S; Ndoje G; Marco E; Moses M; Makani J
    Front Pediatr; 2022; 10():826199. PubMed ID: 36160767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
    Odame I
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological complications of sickle cell disease in Africa: protocol for a systematic review.
    Mengnjo MK; Kamtchum-Tatuene J; Nicastro N; Noubiap JJ
    BMJ Open; 2016 Oct; 6(10):e012981. PubMed ID: 27798028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa).
    Adewoyin AS
    Anemia; 2015; 2015():791498. PubMed ID: 25667774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.
    Bello-Manga H; DeBaun MR; Kassim AA
    Expert Rev Hematol; 2016 Nov; 9(11):1031-1042. PubMed ID: 27677923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.